These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 24482427)

  • 1. Reactive oxygen species-scavenging nanomedicines for the treatment of oxidative stress injuries.
    Yoshitomi T; Nagasaki Y
    Adv Healthc Mater; 2014 Aug; 3(8):1149-61. PubMed ID: 24482427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles.
    Yoshitomi T; Hirayama A; Nagasaki Y
    Biomaterials; 2011 Nov; 32(31):8021-8. PubMed ID: 21816462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of an oral nanotherapeutics using redox nanoparticles for treatment of colitis-associated colon cancer.
    Vong LB; Yoshitomi T; Matsui H; Nagasaki Y
    Biomaterials; 2015 Jul; 55():54-63. PubMed ID: 25934452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.
    Yoshitomi T; Ozaki Y; Thangavel S; Nagasaki Y
    J Control Release; 2013 Nov; 172(1):137-143. PubMed ID: 23958903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox nanoparticles inhibit curcumin oxidative degradation and enhance its therapeutic effect on prostate cancer.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    J Control Release; 2015 Jul; 209():110-9. PubMed ID: 25912409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroxyl radical-containing nanoparticles for novel nanomedicine against oxidative stress injury.
    Yoshitomi T; Nagasaki Y
    Nanomedicine (Lond); 2011 Apr; 6(3):509-18. PubMed ID: 21542688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of oral pH-sensitive redox nanotherapeutics for gastric ulcer therapy.
    Tang MQ; Tran NB; Nguyen TT; Nguyen KH; Trinh NT; Van Vo T; Kobayashi M; Yoshitomi T; Nagasaki Y; Vong LB
    J Control Release; 2024 Nov; 375():758-766. PubMed ID: 39326501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel neuroprotection using antioxidant nanoparticles in a mouse model of head trauma.
    Takahashi T; Marushima A; Nagasaki Y; Hirayama A; Muroi A; Puentes S; Mujagic A; Ishikawa E; Matsumura A
    J Trauma Acute Care Surg; 2020 May; 88(5):677-685. PubMed ID: 32039974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Redox nanoparticle increases the chemotherapeutic efficiency of pioglitazone and suppresses its toxic side effects.
    Thangavel S; Yoshitomi T; Sakharkar MK; Nagasaki Y
    Biomaterials; 2016 Aug; 99():109-23. PubMed ID: 27235996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An orally administered redox nanoparticle that accumulates in the colonic mucosa and reduces colitis in mice.
    Vong LB; Tomita T; Yoshitomi T; Matsui H; Nagasaki Y
    Gastroenterology; 2012 Oct; 143(4):1027-36.e3. PubMed ID: 22771506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.
    Sha S; Vong LB; Chonpathompikunlert P; Yoshitomi T; Matsui H; Nagasaki Y
    Biomaterials; 2013 Nov; 34(33):8393-400. PubMed ID: 23896000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-Assembling Antioxidants for Ischemia-Reperfusion Injuries.
    Yoshitomi T; Nagasaki Y
    Antioxid Redox Signal; 2022 Jan; 36(1-3):70-80. PubMed ID: 34074133
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of silica-containing redox nanoparticles for medical applications.
    Yoshitomi T; Nagasaki Y
    Biomater Sci; 2015 Jun; 3(6):810-5. PubMed ID: 26221840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination Treatment of Murine Colon Cancer with Doxorubicin and Redox Nanoparticles.
    Vong LB; Nagasaki Y
    Mol Pharm; 2016 Feb; 13(2):449-55. PubMed ID: 26605906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-sensitive radical-containing-nanoparticle (RNP) for the L-band-EPR imaging of low pH circumstances.
    Yoshitomi T; Suzuki R; Mamiya T; Matsui H; Hirayama A; Nagasaki Y
    Bioconjug Chem; 2009 Sep; 20(9):1792-8. PubMed ID: 19685867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Toxicity and Antioxidant Activity of Redox Nanoparticles in Zebrafish (Danio rerio) Embryos.
    Vong LB; Kobayashi M; Nagasaki Y
    Mol Pharm; 2016 Sep; 13(9):3091-7. PubMed ID: 27186993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Design of New Cancer Nanotherapeutics Which Controls Active Gaseous Molecules in Vivo].
    Nagasaki Y
    Yakugaku Zasshi; 2018; 138(7):911-918. PubMed ID: 29962468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery.
    Nagasaki Y
    Ther Deliv; 2012 Feb; 3(2):165-79. PubMed ID: 22834195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovascular Unit Protection From Cerebral Ischemia-Reperfusion Injury by Radical-Containing Nanoparticles in Mice.
    Hosoo H; Marushima A; Nagasaki Y; Hirayama A; Ito H; Puentes S; Mujagic A; Tsurushima H; Tsuruta W; Suzuki K; Matsui H; Matsumaru Y; Yamamoto T; Matsumura A
    Stroke; 2017 Aug; 48(8):2238-2247. PubMed ID: 28655813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulation of tissue plasminogen activator in pH-sensitive self-assembled antioxidant nanoparticles for ischemic stroke treatment - Synergistic effect of thrombolysis and antioxidant.
    Mei T; Kim A; Vong LB; Marushima A; Puentes S; Matsumaru Y; Matsumura A; Nagasaki Y
    Biomaterials; 2019 Sep; 215():119209. PubMed ID: 31181394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.